We would like to place cookies on your computer to help us make this website better. To find out more about the cookies, see our privacy notice.

EUBREAST Network – AXSANA

AXillary Surgery After NeoAdjuvant Treatment

 

A prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy

 

 

Based on the lack of sufficient evidence and discrepancies between different national and institutional standards, EUBREAST decided to initiate a prospective cohort study as an international project that aims at comparatively evaluating data on axillary staging after neoadjuvant therapy. Since AXSANA aims at analyzing the clinical landscape of axillary surgery, study sites participating in the AXSANA are free to use any technique they choose.

 

Below please find:

International Steering Board

Organizing Committee

National Steering Committee

Documents For Download

Country-specific Documents For Download

AXSANA Newsletters

Publications

Conference Proceedings

AXSANA Videos (Including Initiation Video in English)

Project Support

 

 

 

International Steering Board

 

Organizing Committee

 

eCRF documentation

 

The eCRF documentation is available at https://eubreast-axsana.com

 

National Steering Committee

 

In case of questions do not hesitate to contact us at info@eubreast.com or the Study Coordinartor: DR BILGE AKTAS SEZEN. 
If you wish to participate in AXSANA, please contact your National Steering Committee:

 

The following documents are available for download:

 

Current documents in English:

  

Country-specific documents are available here:

 

Albania

 

Austria

 

Azerbaijan

Belgium

Bulgaria

Czech Republic

 

Finland

France

 

Germany:

Greece:

 

Hong Kong

Hungary

 

India

Israel

Italy:

 *Please note that from time to time there are minor redactional changes in the protocol (for example, each time the Sponsor adds a new country and therefore a new Head of Steering Committee). When this occurs, the Sponsor only changes the last number of the Protocol. The last substantial amendment made to the Protocol was Version 5.0 (and therefore, the version approved by the ethical committee of the Coordinating Hospital in Italy). Since that approved version of the Protocol, the Sponsor declares to have only made redactional changes to the names of Heads of Steering Committees (5.0.1, 5.0.2, 5.0.3 and so on).

 

IMexico

Norway:

 

Peru:

 

Poland:

 

Portugal

 

Romania:

 

Russia:

Slovenia

Spain

 

Sweden:

 

Switzerland

Thailand

Turkey

 

United Kingdom

 

 

AXSANA newsletters:

  

Publications:

 

 

Conference Proceedings:

 

 Video: Prof. Dr. med. Thorsten Kühn - SABCS

 

 

Video abstract of the AXSANA publication in Cancers 2021

 

Before study sites start recruiting patients, they are kindly asked to participate in an initiation presentation either via videoconference or by watching the following video (please inform your National Steering Committee afterwards so that your study site can be considered initiated):

 

Initiation video in English

 

Initiation video in German:

 

 

The financial support for the AXSANA study has been provided by:

AGO-B            Claudia von Schilling         

AWO Gyn        endomag

Mammotome         

Ehmann Stiftung

 

 

 

Further, the AXSANA study is supported by:  

 

     

 

In case of questions do not hesitate to contact us at info@eubreast.com